Records containing: Hodgkin Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-06-26A Pharmacodynamically-Guided Dose Escalation Phase I Study to Assess the Safety of AFM13 (Recombinant Antibody Construct Against Human CD30 and CD16A) in Patients With Refractory and/or Relapsed Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2013-06-12Screening for Coronary Artery Disease After Mediastinal Irradiation in Hodgkin Lymphoma Survivors
-
CLINICAL_TRIALS study record update · 2013-05-07Risk-Adapted Therapy for Pediatric Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2013-03-15A Phase 2 Safety and Efficacy Study of Orally Administered PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2013-03-05Phase II Study of IGEV Followed by Autologous Stem Cell Transplantation in Patients With Refractory or Relapsed Hodgkin Lymphoma.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-01-09Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
-
CLINICAL_TRIALS study record update · 2012-07-09Phase-I Study of Bortezomib (VELCADE) Plus ICE (Ifosfamide, Carboplatin, Etoposide) for Patients With Relapsed Classical Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2012-04-20A Phase 2 Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2012-02-23A Phase I Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Immunoregulatory Activity, and Preliminary Antitumor Activity of Anti-Programmed-Death-Ligand 1 (PD-L1) Antibody (BMS-936559) in Subjects With Relapsed or Refractory Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2010-01-12ClinicalTrials.gov study NCT00301314
-
CLINICAL_TRIALS study record update · 2009-11-13Observational Retrospective Study to Evaluate the Incidence of the Gonadal Toxicity in Women of Reproductive Age With Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2009-08-11Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies